Symbols

Symbols

AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial

CASI(Delisted)

CASI Pharmaceuticals·NASDAQ

--

--(--)

Stock Overview

0.00 / 10Overall Score

—Investment Rating

RiskExcellent

Drawing on fundamental quality of 0.00/10, technical read of 0.00/10, and market sentiment of 0.00/10, CASI's overall diagnostic stands at 0.00/10 — a — rating.
The five-dimensional fundamental profile of CASI — Value 0.00, Future 0.00, Past 0.00, Health 0.00, Dividend 0.00 — aggregates to 0.00/10, earning a — rating.
Weighing recent momentum, trend, and candlestick pattern signals, CASI's technical footprint settles at 0.00/10 — rated —.
The combined read of institutional fund flow activity and sell-side analyst consensus places CASI's market sentiment at 0.00/10 — a — rating.

Shareholder Returns

CASIIndustryMarket

7 Day------

30 Day------

90 Day------

1 Year------

3 Year------

5 Year------

Include Dividend Returns

CASI Pharmaceuticals Corporation Fundamentals Summary

--P/E Ratio

--P/S Ratio

--P/B Ratio

Market cap--

Earnings--

Revenue--

Trend Analysis of CASI

Based on a composite score of 3.73/10, we rate CASI as a Netural. Our analysis breaks down into 5.57/10 for Fundamentals, 1.69/10 for Technicals, and 3.84/10 for Sentiment, indicating the stock is likely to consolidate sideways.

Is CASI undervalued or overvalued?

Technical Analysis of CASI

Is money flowing into or out of CASI?